Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03248258 · ClinicalTrials.gov registry record
Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 200
- Enrollment target
NCT03248258: Completed study, sponsored by University of Alabama at Birmingham.
NCT03248258 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03248258 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Develop a Metastatic Breast Cancer (MBC)-specific electronic Treatment Plans (TP). Phase 1: Aim 1a: Patient interviews along with navigator, nurse, and physician focus group discussions will be used to identify factors that influence decision-making in treatment selection and the optimal approach for sharing information about prognosis and guideline-based care. Identify decisional needs for Shared Decision Making (SDM) in MBC. Investigators will conduct semi-structured interviews/discussion groups with patients, navigators, nurses, and physicians to elements important to decision-making. Phase 2: Aim 1b: Develop MBC-specific TP. Investigators will build upon Aim1a to systematically develop the TP intervention using the Ottawa Decision Support Framework. Investigators will test the TPs with 5 patients and conduct qualitative investigations to refine the TP using an iterative process. Phase 3:Further explore decision-making related to reducing amount of chemotherapy for patients with good prognosis.
Primary Outcome
Shared decision making occurs when patients are informed of risks and benefits associated with treatment options and partner with their oncologist to incorporate their personal preferences and values into decision-making. Shared decision making in medicine can improve quality of care and reduce costs. This will be accessed using qualitative interviews and focus groups discussions. This is not a survey based study.
Interventions
- OTHER Qualitative Interview or Focus group discussions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-06-27 |
| Est. Completion | 2022-12-31 |
What the finished NCT03248258 record still lists
NCT03248258 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Qualitative Interview or Focus group discussions is the first listed.
NCT03248258 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03248258 about?
NCT03248258 is a clinical study titled "Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)". Develop a Metastatic Breast Cancer (MBC)-specific electronic Treatment Plans (TP). Phase 1: Aim 1a: Patient interviews along with navigator, nurse, and physician focus group discussions will be used to identify factors that influence decision-making in treatment selection and the optimal approach ...
What is the current status of trial NCT03248258?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2017-06-27. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT03248258?
The interventions under investigation include: Qualitative Interview or Focus group discussions (OTHER).
Who is sponsoring clinical trial NCT03248258?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI